Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Vesuvius adopts cautious outlook as sales, profits weaken

(Sharecast News) - Vesuvius adopted a cautious stance on Thursday, after it warned that the introduction of tariffs on an already under-pressure global steel market could curb profits. Posting full-year results, the firm - a specialist in molten metal flow engineering and technology - said revenues fell nearly 6% in 2024 to £1.8bn, or by 2% once the impact of currency fluctuations had been stripped out.

Earnings before interest, tax and amortisation declined 6% to £188m, while headline basic earnings per share were 43.3p, down 7%.

Vesuvius said a "difficult market background" had affected both its steel and foundry units.

Patrick Andre, chief executive, said: "This has been a challenging year for Vesuvius, with foundry markets in Europe, North Asia and the Americas weakening significantly, and global steel production outside of China negatively affected by the sharp increase of Chinse steel exports.

"Despite this, thanks to significant cost-cutting, resilient pricing and market share gains, we have delivered a robust performance, maintaining our results at the level of 2023 on an underlying basis."

Looking to the current year, however, Andre acknowledged that the difficult geopolitical climate, including the imposition of tariffs, could hit profits.

He said: "While we remain confident in our own performance, we are cautious on market conditions, due to the uncertain economic environment arising from the negative impact of trade tariffs - which continue to evolve - geopolitical volatility and the continuing structural weakness of steel and foundry markets in Europe.

"We currently anticipate that our trading profits in 2025 will be at a broadly similar level to 2025 on a constant currency basis."

Cashflow, however, was forecast to be "significantly" ahead of 2024, boosted by a focus on working capital and reduced capital expenditure.

Jefferies, which has a 'buy' rating on the FTSE 250 stock, said: "Management again executed well in a challenging market. Net debt was higher than [our estimates] but the balance sheet is in good shape.

"Despite some positive macro developments, management again guides cautiously, which will likely see the 2025 full year consensus trading profit more lower, possibly by mid to high single digits."

As at 1045 GMT, shares in Vesuvius were largely flat at 409.5p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.